Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugs
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Jun-Young | - |
dc.contributor.author | Lee, Gyu-Ho | - |
dc.contributor.author | Yoo, Kwai Han | - |
dc.contributor.author | Khang, Dongwoo | - |
dc.date.accessioned | 2023-03-03T01:40:04Z | - |
dc.date.available | 2023-03-03T01:40:04Z | - |
dc.date.created | 2023-02-14 | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 1477-3155 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/86971 | - |
dc.description.abstract | Despite the development of therapeutic modalities to treat cancer, multidrug resistance (MDR) and incomplete destruction of deeply embedded lung tumors remain long-standing problems responsible for tumor recurrence and low survival rates. Therefore, developing therapeutic approaches to treat MDR tumors is necessary. In this study, nanodrugs with enhanced intracellular drug internalization were identified by the covalent bonding of carbon nanotubes of a specific nano size and doxorubicin (DOX). In addition, carbon nanotube conjugated DOX (CNT-DOX) sustained in the intracellular environment in multidrug-resistant tumor cells for a long time causes mitochondrial damage, suppresses ATP production, and results in the effective therapeutic effect of drug-resistant tumors. This study identified that H69AR lung cancer cells, an adriamycin (DOX) drug-resistant tumor cell line, did not activate drug resistance function on designed nano-anticancer drugs with a specific nano size. In summary, this study identified that the specific size of the nanodrug in combination with DOX overcame multidrug-resistant tumors by inducing selective accumulation in tumor cells and inhibiting ATP by mitochondrial damage. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.relation.isPartOf | JOURNAL OF NANOBIOTECHNOLOGY | - |
dc.title | Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugs | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000913418600001 | - |
dc.identifier.doi | 10.1186/s12951-023-01768-8 | - |
dc.identifier.bibliographicCitation | JOURNAL OF NANOBIOTECHNOLOGY, v.21, no.1 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85146195011 | - |
dc.citation.title | JOURNAL OF NANOBIOTECHNOLOGY | - |
dc.citation.volume | 21 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Park, Jun-Young | - |
dc.contributor.affiliatedAuthor | Lee, Gyu-Ho | - |
dc.contributor.affiliatedAuthor | Yoo, Kwai Han | - |
dc.contributor.affiliatedAuthor | Khang, Dongwoo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Carbon nanotube | - |
dc.subject.keywordAuthor | Doxorubicin | - |
dc.subject.keywordAuthor | Endosomal escape | - |
dc.subject.keywordAuthor | Multidrug resistant cell | - |
dc.subject.keywordAuthor | Small cell lung cancer | - |
dc.subject.keywordAuthor | Mitochondrial damage | - |
dc.subject.keywordPlus | CARBON NANOTUBES | - |
dc.subject.keywordPlus | TRANSPORTERS | - |
dc.subject.keywordPlus | CONJUGATION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | EFFLUX | - |
dc.subject.keywordPlus | ABCC1 | - |
dc.subject.keywordPlus | MRP1 | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.